Revista

Nome:
Pharmacoeconomics web
Rankings:
Pontos Posição
CEF.UP+NIPE (average of all rankings) (2012) 18.72 250/501
Australian RC (2010) 50.0 325/479
CNRS (2008) 60.0 133/336
Ideas discounted recursive impact factor (2012) 0.08 383/396
ISI, JCR SSE, Article Influence Score (2010) 8.79 108/316
ISI, JCR SSE, Impact Factor (2010) 46.29 14/388
Source Normalized Impact per Paper (SNIP) (2011) 15.34 136/476
Article Influence Score (2019) 1.5 91/428
Impact Factor (2019) 3.56 60/440
Impact Factor (5 year) (2019) 4.57 55/428
SJR - Scimago (2019) 1.45 141/549
Count (2020) 1.0 51/644
Artigos 3:

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials.
Rita Faria, Manuel Gomes, David Epstein, Ian White
vol. 32, 2014, p. 1157-1170.

Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis.
Marta O Soares, Luısa Canto e Castro
vol. 30, 2012, p. 1101-1117.

Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries
Carlos Gouveia Pinto, A. Lafuma, F. Fagnani, M.J.C. Nuijten, G. Berdeaux
vol. 19, 2001, p. 255-265.

Voltar